Young-Joon Surh

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 12

Top Topics

Endoplasmic Reticulum

Tyrosine Kinase

Hyaluronic Acid

Breast Cancer Cells

Top Venues

Molecules and cells

FASEB journal : official publication of the Federation of American Societies for Experimental Biology

Journal of cancer prevention

This page only lists publications with an associated author ORCID identifier.

Publications

Su-Jung Kim, Young-Joon Surh
The Multifaceted Roles for NRF2 in Regulating Tumor Development and Progression: An Update. Molecules and cells 46 (3) (2023)
Du Hyun Song, Na Young Kim, Hyeong Ho Jo, Sang Bin Kim, Yonghoon Choi, Hyeon Jeong Oh, Hye Seung Lee, Hyuk Yoon, Cheol Min Shin, Young Soo Park, Dong Ho Lee, So Hyun Kang, Young Suk Park, Sang-Hoon Ahn, Yun Suhk Suh, Do Joong Park, Hyung-Ho Kim, Ji-Won Kim, Jin Won Kim, Keun-Wook Lee, Won Chang, Ji Hoon Park, Yoon Jin Lee, Kyoung Ho Lee, Young Hoon Kim, Soyeon Ahn, Young-Joon Surh
Analysis of Characteristics and Risk Factors of Patients with Single Gastric Cancer and Synchronous Multiple Gastric Cancer among 14,603 Patients. Gut and liver (2023)
Su-Jung Kim, Young-Joon Surh
The Multifaceted Roles for NRF2 in Regulating Tumor Development and Progression: An Update. Molecules and cells 46 (3) (2023)
Soma Saeidi, Su-Jung Kim, Yanymee N Guillen-Quispe, Achanta Sri Venkata Jagadeesh, Hyeong-Jun Han, Seung Hyeon Kim, Xiancai Zhong, Juan-Yu Piao, Seong-Jin Kim, Joon Jeong, Yun Jin Shin, Yoon Jin Cha, Han-Byoel Lee, Wonshik Han, Sang-Hyun Min, Wang Tian, Hiroshi Kitamura, Young-Joon Surh
Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 36 (1) (2022)
Yeon-Hwa Lee, Su-Jung Kim, Xizhu Fang, Na-Young Song, Do-Hee Kim, Jinyoung Suh, Hye-Kyung Na, Kyung-Ok Kim, Jeong-Heum Baek, Young-Joon Surh
JNK-mediated Ser27 phosphorylation and stabilization of SIRT1 promote growth and progression of colon cancer through deacetylation-dependent activation of Snail. Molecular oncology (2021)
Shin-Young Gwak, Su-Jung Kim, Jeongmin Park, Seung Hyeon Kim, Yeonsoo Joe, Ha-Na Lee, Wonki Kim, Ishrat Aklima Muna, Hye-Kyung Na, Hun Taeg Chung, Young-Joon Surh
Potential Role of Heme Oxygenase-1 in the Resolution of Experimentally Induced Colitis through Regulation of Macrophage Polarization. Gut and liver (2021)
Su-Jung Kim, Nam-Chul Cho, Bitnara Han, Kyeojin Kim, Young-Il Hahn, Kwang-Pyo Kim, Young-Ger Suh, Bu Young Choi, Hye-Kyung Na, Young-Joon Surh
15-Deoxy-Δ12,14 -prostaglandin J2 binds and inactivates STAT3 via covalent modification of cysteine 259 in H-Ras-transformed human breast epithelial cells. FEBS letters 595 (5) (2021)
Hyo-Jin Yoon, Young-Joon Surh
Modulation of Cancer Cell Growth and Progression by Caveolin-1 in the Tumor Microenvironment. Advances in experimental medicine and biology 1277 (2021)
Ha-Na Lee, Yeon-Seo Choi, Seong Hoon Kim, Xiancai Zhong, Wonki Kim, Joon Sung Park, Soma Saeidi, Byung Woo Han, Nayoung Kim, Hye Seung Lee, Yoon Jin Choi, Jeong-Heum Baek, Hye-Kyung Na, Young-Joon Surh
Resolvin D1 suppresses inflammation-associated tumorigenesis in the colon by inhibiting IL-6-induced mitotic spindle abnormality. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35 (5) (2021)
Jinyoung Suh, Do-Hee Kim, Yeon-Hwa Lee, Jeong-Hoon Jang, Young-Joon Surh
Fibroblast growth factor-2, derived from cancer-associated fibroblasts, stimulates growth and progression of human breast cancer cells via FGFR1 signaling. Molecular carcinogenesis 59 (9) (2020)
Sin-Aye Park, Nam Ji Sung, Bae-Jung Choi, Wonki Kim, Seung Hyeon Kim, Young-Joon Surh
Gremlin-1 augments the oestrogen-related receptor α signalling through EGFR activation: implications for the progression of breast cancer. British journal of cancer 123 (6) (2020)
Ga Yun Kim, Jinyoung Suh, Jeong-Hoon Jang, Do-Hee Kim, Ock Jin Park, Sue-Kyung Park, Young-Joon Surh
Genistein Inhibits Proliferation of BRCA1 Mutated Breast Cancer Cells: The GPR30-Akt Axis as a Potential Target. Journal of cancer prevention 24 (4) (2019)